Differential internalization of the prostaglandin F receptor isoforms

Role of protein kinase C and clathrin

Dinesh Srinivasan, Hiromichi Fujino, John W Regan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

FP prostanoid receptors are G-protein-coupled receptors that mediate the actions of prostaglandin F (PGF). Alternative mRNA splicing gives rise to two isoforms, FPA and FPB, which are identical except for their intracellular carboxyl termini. In this study, we examined the internalization of recombinant FLAG- epitope-tagged FPA and FPB receptors that were stably expressed in human embryonic kidney-293 cells. Cell surface receptors on live cells were labeled with anti-FLAG antibodies either in the presence or absence of PGF and were examined by immunofluorescence microscopy. In the absence of PGF, FPA-expressing cells were labeled predominantly on the cell surface; however, FPB-expressing cells were labeled on both the cell surface and intracellularly, indicating constitutive internalization of the FPB isoform. After treatment with PGF, FPA expressing cells were labeled intracellularly, reflecting receptor internalization, which could be mimicked with phorbol 12-myristyl 13-acetate (PMA), an activator of protein kinase C (PKC). Pretreatment of FPA-expressing cells with GÖ 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo5H-indolo[2,3-a] pyrrolo[3,4-c]carbozole], an inhibitor of PKC, blocked both PGF- and PMA-induced receptor internalization. However, GÖ 6976 did not block constitutive internalization of the FPB isoform, suggesting that the mechanisms of receptor internalization differ between the FPA and FPB isoforms. Furthermore, pretreatment with sucrose, an inhibitor of clathrin-dependent internalization, blocked PGF-induced internalization of the FPA isoform but did not block constitutive internalization of the FPB isoform. In conclusion, the FPA receptor isoform shows an agonist-induced internalization involving PKC and clathrin, whereas the FPB isoform undergoes agonist-independent internalization that does not involve PKC or clathrin.

Original languageEnglish (US)
Pages (from-to)219-224
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume302
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Clathrin
Protein Kinase C
Dinoprost
Protein Isoforms
Acetates
Gastrin-Secreting Cells
prostaglandin F2alpha receptor
Alternative Splicing
Cell Surface Receptors
G-Protein-Coupled Receptors
Fluorescence Microscopy
Sucrose
Epitopes
Anti-Idiotypic Antibodies
Kidney
Messenger RNA

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential internalization of the prostaglandin F receptor isoforms : Role of protein kinase C and clathrin. / Srinivasan, Dinesh; Fujino, Hiromichi; Regan, John W.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 302, No. 1, 2002, p. 219-224.

Research output: Contribution to journalArticle

@article{3241c0b6b52541b980fafc3244e06735,
title = "Differential internalization of the prostaglandin F2α receptor isoforms: Role of protein kinase C and clathrin",
abstract = "FP prostanoid receptors are G-protein-coupled receptors that mediate the actions of prostaglandin F2α (PGF2α). Alternative mRNA splicing gives rise to two isoforms, FPA and FPB, which are identical except for their intracellular carboxyl termini. In this study, we examined the internalization of recombinant FLAG- epitope-tagged FPA and FPB receptors that were stably expressed in human embryonic kidney-293 cells. Cell surface receptors on live cells were labeled with anti-FLAG antibodies either in the presence or absence of PGF2α and were examined by immunofluorescence microscopy. In the absence of PGF2α, FPA-expressing cells were labeled predominantly on the cell surface; however, FPB-expressing cells were labeled on both the cell surface and intracellularly, indicating constitutive internalization of the FPB isoform. After treatment with PGF2α, FPA expressing cells were labeled intracellularly, reflecting receptor internalization, which could be mimicked with phorbol 12-myristyl 13-acetate (PMA), an activator of protein kinase C (PKC). Pretreatment of FPA-expressing cells with G{\"O} 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo5H-indolo[2,3-a] pyrrolo[3,4-c]carbozole], an inhibitor of PKC, blocked both PGF2α- and PMA-induced receptor internalization. However, G{\"O} 6976 did not block constitutive internalization of the FPB isoform, suggesting that the mechanisms of receptor internalization differ between the FPA and FPB isoforms. Furthermore, pretreatment with sucrose, an inhibitor of clathrin-dependent internalization, blocked PGF2α-induced internalization of the FPA isoform but did not block constitutive internalization of the FPB isoform. In conclusion, the FPA receptor isoform shows an agonist-induced internalization involving PKC and clathrin, whereas the FPB isoform undergoes agonist-independent internalization that does not involve PKC or clathrin.",
author = "Dinesh Srinivasan and Hiromichi Fujino and Regan, {John W}",
year = "2002",
doi = "10.1124/jpet.302.1.219",
language = "English (US)",
volume = "302",
pages = "219--224",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Differential internalization of the prostaglandin F2α receptor isoforms

T2 - Role of protein kinase C and clathrin

AU - Srinivasan, Dinesh

AU - Fujino, Hiromichi

AU - Regan, John W

PY - 2002

Y1 - 2002

N2 - FP prostanoid receptors are G-protein-coupled receptors that mediate the actions of prostaglandin F2α (PGF2α). Alternative mRNA splicing gives rise to two isoforms, FPA and FPB, which are identical except for their intracellular carboxyl termini. In this study, we examined the internalization of recombinant FLAG- epitope-tagged FPA and FPB receptors that were stably expressed in human embryonic kidney-293 cells. Cell surface receptors on live cells were labeled with anti-FLAG antibodies either in the presence or absence of PGF2α and were examined by immunofluorescence microscopy. In the absence of PGF2α, FPA-expressing cells were labeled predominantly on the cell surface; however, FPB-expressing cells were labeled on both the cell surface and intracellularly, indicating constitutive internalization of the FPB isoform. After treatment with PGF2α, FPA expressing cells were labeled intracellularly, reflecting receptor internalization, which could be mimicked with phorbol 12-myristyl 13-acetate (PMA), an activator of protein kinase C (PKC). Pretreatment of FPA-expressing cells with GÖ 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo5H-indolo[2,3-a] pyrrolo[3,4-c]carbozole], an inhibitor of PKC, blocked both PGF2α- and PMA-induced receptor internalization. However, GÖ 6976 did not block constitutive internalization of the FPB isoform, suggesting that the mechanisms of receptor internalization differ between the FPA and FPB isoforms. Furthermore, pretreatment with sucrose, an inhibitor of clathrin-dependent internalization, blocked PGF2α-induced internalization of the FPA isoform but did not block constitutive internalization of the FPB isoform. In conclusion, the FPA receptor isoform shows an agonist-induced internalization involving PKC and clathrin, whereas the FPB isoform undergoes agonist-independent internalization that does not involve PKC or clathrin.

AB - FP prostanoid receptors are G-protein-coupled receptors that mediate the actions of prostaglandin F2α (PGF2α). Alternative mRNA splicing gives rise to two isoforms, FPA and FPB, which are identical except for their intracellular carboxyl termini. In this study, we examined the internalization of recombinant FLAG- epitope-tagged FPA and FPB receptors that were stably expressed in human embryonic kidney-293 cells. Cell surface receptors on live cells were labeled with anti-FLAG antibodies either in the presence or absence of PGF2α and were examined by immunofluorescence microscopy. In the absence of PGF2α, FPA-expressing cells were labeled predominantly on the cell surface; however, FPB-expressing cells were labeled on both the cell surface and intracellularly, indicating constitutive internalization of the FPB isoform. After treatment with PGF2α, FPA expressing cells were labeled intracellularly, reflecting receptor internalization, which could be mimicked with phorbol 12-myristyl 13-acetate (PMA), an activator of protein kinase C (PKC). Pretreatment of FPA-expressing cells with GÖ 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo5H-indolo[2,3-a] pyrrolo[3,4-c]carbozole], an inhibitor of PKC, blocked both PGF2α- and PMA-induced receptor internalization. However, GÖ 6976 did not block constitutive internalization of the FPB isoform, suggesting that the mechanisms of receptor internalization differ between the FPA and FPB isoforms. Furthermore, pretreatment with sucrose, an inhibitor of clathrin-dependent internalization, blocked PGF2α-induced internalization of the FPA isoform but did not block constitutive internalization of the FPB isoform. In conclusion, the FPA receptor isoform shows an agonist-induced internalization involving PKC and clathrin, whereas the FPB isoform undergoes agonist-independent internalization that does not involve PKC or clathrin.

UR - http://www.scopus.com/inward/record.url?scp=0036082357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036082357&partnerID=8YFLogxK

U2 - 10.1124/jpet.302.1.219

DO - 10.1124/jpet.302.1.219

M3 - Article

VL - 302

SP - 219

EP - 224

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -